Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer

Completed

Conditions studied: Breast Cancer Stage IV, Breast Cancer Stage I, Breast Cancer Stage II

In brief

We propose to quantitate endothelial progenitor cells (EPCs) in early and advanced breast cancer patients. Peripheral blood will be drawn from the eligible patients. Different type of EPCs will be isolated from the blood and quantitated.

Key facts

Study ID

NCT00393341

Run by

Indiana University

People needed

68

Starts

2006-10-01

Expected to finish

2009-08-01

Last updated by the study team

2015-08-31

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of metastatic breast cancer(stage IV), or women with a history of Stage I or II breast cancer disease who are currently disease free Women greater than or equal to 18 years of age Ability to understand and the willingness to sign an informed consent

You may not qualify if…

• Chemotherapy, radiation, or surgery within the past 4 weeks.

Where it is running

• Indiana University — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.